CIPLA.NS · Cipla Limited
India · RS rating 50 · As of 2026-10-14
| Price | 1,314.60 INR |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 50 / 50 / 42 / 51 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 36 / 21 / 56 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | +42.3% |
| Sales growth Q/Q | +9.5% |
| Distance from 52-week high | +21.0% |
| Market cap (USD) | $11.0B |